83 related articles for article (PubMed ID: 33895004)
1. Model-Guided Decision-Making for Thromboprophylaxis and Hospital-Acquired Thromboembolic Events Among Hospitalized Children and Adolescents: The CLOT Randomized Clinical Trial.
Walker SC; French B; Moore RP; Domenico HJ; Wanderer JP; Mixon AS; Creech CB; Byrne DW; Wheeler AP
JAMA Netw Open; 2023 Oct; 6(10):e2337789. PubMed ID: 37831448
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolism Risk and Adherence to Pharmacological Thromboprophylaxis in Hospitalized Patients in Uruguay: First Nationwide Study.
Mérola V; Pizzarossa AC; López M; Peverelli F; Bruno G; González M; Roca F; Dentone L; Pérez G; Da Silveira L; Díaz L; Tafuri J; Cuadro R; Zaquiere M; Bartaburu G; Pacello F; Celio C; López MJ; Viana M; Fraga L; Blanco V; Chalart P; Leal D; Rodríguez X; Teti L; Goñi C; Infante E; Prícoli A; Altieri V; Guillermo C; Martínez R
Clin Appl Thromb Hemost; 2024; 30():10760296241256368. PubMed ID: 38798129
[TBL] [Abstract][Full Text] [Related]
3. Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort.
Marando M; Blondon K; Darbellay Farhoumand P; Nendaz M; Grauser D; Sallet A; Tamburello A; Pons M; Righini M; Gianella P; Blondon M
Swiss Med Wkly; 2023 Nov; 153():40117. PubMed ID: 37956238
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of venous thromboembolism in elderly medical patients.
Lacut K; Le Gal G; Mottier D
Clin Interv Aging; 2008; 3(3):399-411. PubMed ID: 18982911
[TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of venous thromboembolism in patients with cancer.
Hogg K; Carrier M
Ther Adv Hematol; 2012 Feb; 3(1):45-58. PubMed ID: 23556111
[TBL] [Abstract][Full Text] [Related]
6. A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19.
Amani-Beni R; Kermani-Alghoraishi M; Darouei B; Reid CM
Egypt Heart J; 2023 Aug; 75(1):72. PubMed ID: 37596465
[TBL] [Abstract][Full Text] [Related]
7. The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients-Rationale and Design of the RICO trial.
Dentali F; Campanini M; Bonaventura A; Fontanella L; Zuretti F; Tavecchia L; Mumoli N; Gnerre P; Ventrella F; Giustozzi M; Valerio A; Fontanella A
TH Open; 2024 Jan; 8(1):e55-e60. PubMed ID: 38222040
[No Abstract] [Full Text] [Related]
8. [Optimal prevention of VTE in cancer surgery patients with impaired renal function].
Katelnitskaya OV; Barashev AA; Ausheva TV
Khirurgiia (Mosk); 2024; (1):119-126. PubMed ID: 38258698
[TBL] [Abstract][Full Text] [Related]
9. Risk of thrombosis and mortality in inflammatory bowel disease.
Andrade AR; Barros LL; Azevedo MFC; Carlos AS; Damião AOMC; Sipahi AM; Leite AZA
Clin Transl Gastroenterol; 2018 Apr; 9(4):142. PubMed ID: 29618721
[TBL] [Abstract][Full Text] [Related]
10. Optimization of Thromboprophylaxis Use in Hospitalized Pediatric Patients Through Implementation of a Venous Thromboembolism Risk Assessment Tool.
Sanchez A; Campanella L; Perez K
J Pediatr Pharmacol Ther; 2023; 28(5):452-456. PubMed ID: 38130498
[TBL] [Abstract][Full Text] [Related]
11. Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
Mulder FI; Bosch FTM; van Es N
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033438
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines.
Charalampous C; Shah D; Kumar S; Chakraborty R
Ann Hematol; 2024 Apr; ():. PubMed ID: 38630132
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.
Prandoni P
Thromb J; 2008 Sep; 6():13. PubMed ID: 18782432
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry.
Beyer-Westendorf J; Marten S; Tittl L; Naue C; Bornhäuser M
TH Open; 2021 Apr; 5(2):e143-e151. PubMed ID: 33969261
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical Patients].
Kantor B; Poénou G; Plaisance L; Toledano E; Mekhloufi Y; Helfer H; Djennaoui S; Mahé I
Rev Med Interne; 2022 Jan; 43(1):9-17. PubMed ID: 33895004
[TBL] [Abstract][Full Text] [Related]
16. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
Di Nisio M; Porreca E
Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
[TBL] [Abstract][Full Text] [Related]
17. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
[TBL] [Abstract][Full Text] [Related]
18. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
MacDougall K; Spyropoulos AC
Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
